624 related articles for article (PubMed ID: 34447385)
1. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
2. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
[TBL] [Abstract][Full Text] [Related]
3. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
4. Few Foxp3⁺ regulatory T cells are sufficient to protect adult mice from lethal autoimmunity.
Mayer CT; Ghorbani P; Kühl AA; Stüve P; Hegemann M; Berod L; Gershwin ME; Sparwasser T
Eur J Immunol; 2014 Oct; 44(10):2990-3002. PubMed ID: 25042334
[TBL] [Abstract][Full Text] [Related]
5. Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice.
Christiaansen AF; Boggiatto PM; Varga SM
J Immunol Methods; 2014 Apr; 406():58-65. PubMed ID: 24642426
[TBL] [Abstract][Full Text] [Related]
6. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
7. Reversal of New Onset Type 1 Diabetes by Oral
Mbongue JC; Rawson J; Garcia PA; Gonzalez N; Cobb J; Kandeel F; Ferreri K; Husseiny MI
Front Immunol; 2019; 10():320. PubMed ID: 30863412
[TBL] [Abstract][Full Text] [Related]
8. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
9. Peripherally induced regulatory T cells contribute to the control of autoimmune diabetes in the NOD mouse model.
Schuster C; Jonas F; Zhao F; Kissler S
Eur J Immunol; 2018 Jul; 48(7):1211-1216. PubMed ID: 29604048
[TBL] [Abstract][Full Text] [Related]
10. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
[TBL] [Abstract][Full Text] [Related]
11. Selective ablation of thymic and peripheral Foxp3
Yilmazer A; Zevla DM; Malmkvist R; Rodríguez CAB; Undurraga P; Kirgin E; Boernert M; Voehringer D; Kershaw O; Schlenner S; Kretschmer K
Front Immunol; 2023; 14():1298938. PubMed ID: 38164128
[TBL] [Abstract][Full Text] [Related]
12. In vivo depletion of FoxP3+ Tregs using the DEREG mouse model.
Lahl K; Sparwasser T
Methods Mol Biol; 2011; 707():157-72. PubMed ID: 21287334
[TBL] [Abstract][Full Text] [Related]
13. Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes.
Ling Q; Shen L; Zhang W; Qu D; Wang H; Wang B; Liu Y; Lu J; Zhu D; Bi Y
Mol Med; 2022 Feb; 28(1):18. PubMed ID: 35123388
[TBL] [Abstract][Full Text] [Related]
14. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors.
D'Alise AM; Auyeung V; Feuerer M; Nishio J; Fontenot J; Benoist C; Mathis D
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19857-62. PubMed ID: 19073938
[TBL] [Abstract][Full Text] [Related]
15. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
Sgouroudis E; Albanese A; Piccirillo CA
J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.
Madec AM; Mallone R; Afonso G; Abou Mrad E; Mesnier A; Eljaafari A; Thivolet C
Diabetologia; 2009 Jul; 52(7):1391-9. PubMed ID: 19421731
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells.
Kaminitz A; Mizrahi K; Yaniv I; Stein J; Askenasy N
J Autoimmun; 2010 Sep; 35(2):145-52. PubMed ID: 20638242
[TBL] [Abstract][Full Text] [Related]
18. Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model.
Holohan DR; Van Gool F; Bluestone JA
PLoS One; 2019; 14(10):e0217728. PubMed ID: 31647813
[TBL] [Abstract][Full Text] [Related]
19. Human amylin induces CD4+Foxp3+ regulatory T cells in the protection from autoimmune diabetes.
Zhang XX; Qiao YC; Li W; Zou X; Chen YL; Shen J; Liao QY; Zhang QJ; He L; Zhao HL
Immunol Res; 2018 Feb; 66(1):179-186. PubMed ID: 28983871
[TBL] [Abstract][Full Text] [Related]
20. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
